| 000 | 01874 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250511200700.0 | ||
| 264 | 0 | _c19920113 | |
| 008 | 199201s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/83.24.1797-a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolmes, F A | |
| 245 | 0 | 0 |
_aPhase II trial of taxol, an active drug in the treatment of metastatic breast cancer. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cDec 1991 |
||
| 300 |
_a1797-805 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAgranulocytosis _xchemically induced |
| 650 | 0 | 4 |
_aAlkaloids _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscular Diseases _xchemically induced |
| 650 | 0 | 4 | _aPaclitaxel |
| 650 | 0 | 4 |
_aPain _xchemically induced |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aSoft Tissue Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 700 | 1 | _aWalters, R S | |
| 700 | 1 | _aTheriault, R L | |
| 700 | 1 | _aForman, A D | |
| 700 | 1 | _aNewton, L K | |
| 700 | 1 | _aRaber, M N | |
| 700 | 1 | _aBuzdar, A U | |
| 700 | 1 | _aFrye, D K | |
| 700 | 1 | _aHortobagyi, G N | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 83 _gno. 24 _gp. 1797-805 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/83.24.1797-a _zAvailable from publisher's website |
| 999 |
_c1690322 _d1690322 |
||